A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease.
Ann Rheum Dis
; 74(9): 1714-9, 2015 Sep.
Article
in En
| MEDLINE
| ID: mdl-24906637
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Interleukin-1beta
/
Cryopyrin-Associated Periodic Syndromes
/
Antibodies, Monoclonal
Type of study:
Etiology_studies
/
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Child
/
Female
/
Humans
/
Male
Language:
En
Journal:
Ann Rheum Dis
Year:
2015
Type:
Article
Affiliation country:
United States